Restructuring and Pension Charges Drive Cabot's Q3 Earnings Plunge
CBT sits 39% above its 52-week low of $58.33.
Summary
Heavy restructuring charges and a pension settlement masked an otherwise in-line adjusted quarter, as Cabot Corporation reported fiscal Q3 GAAP EPS of $0.12, down sharply from $1.86 a year ago.
Key Events · Earnings and Guidance · CBT
-
Q3 GAAP EPS Plunges to $0.12
Driven by $78 million in certain items, net income attributable to Cabot fell to $6 million, or $0.12 per diluted share, from $101 million, or $1.86, in the prior-year quarter.
-
Restructuring Charges Hit $42 Million
The company recorded $42 million in restructuring costs in Q3, including ceasing carbon black production in Argentina and announcing the closure of multiple units in the Netherlands, with total nine-month charges of $57 million.
-
Pension Settlement Loss of $29 Million
A non-cash settlement loss of $29 million, recorded in other expense, resulted from the termination of two U.K. pension plans.
-
Effective Tax Rate Spikes to 79%
A $19 million discrete tax expense, primarily from a valuation allowance related to the Argentina plant closure, pushed the effective tax rate to 79% for the quarter.
Analysis · CBT · Industrial Applications And Services
Cabot's fiscal Q3 net income collapsed to $6 million from $101 million a year ago, driven by $42 million in restructuring charges tied to plant closures in Argentina and the Netherlands, a $29 million pension settlement loss, and a 79% effective tax rate. While adjusted EPS of $1.67 beat estimates, the GAAP results reveal significant operational upheaval. The company is reshaping its manufacturing footprint amid weaker Reinforcement Materials pricing, and the quarter included a $68 million acquisition in Mexico. The new $1.3 billion credit facility provides liquidity, but the near-term earnings power is clearly impaired.
At the time of this filing, CBT was trading at $81.20 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $58.33 to $94.53. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.